AMEGA Biotech
Buenos Aires, Argentina· Est.
Integrated Argentine biotech delivering biologics and specialty drugs through a full‑stack API‑to‑product platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated Argentine biotech delivering biologics and specialty drugs through a full‑stack API‑to‑product platform.
Technology Platform
Integrated API‑to‑biologic manufacturing platform combining in‑house fermentation, cell‑culture, and downstream purification to produce biologics and specialty drugs under GMP control.
Opportunities
Expansion of biologics and biosimilar offerings across Latin America and potential partnerships with multinational pharma seeking regional manufacturing capacity.
Risk Factors
Regulatory approval challenges, competition from larger biotech firms, and capital intensity required for clinical development and scale‑up.
Competitive Landscape
Competes with regional biotech players and global companies entering Latin America; differentiation lies in its fully integrated API‑to‑product value chain and local market expertise.